Breaking News Instant updates and real-time market news.

TRNF

Taronis Fuels

$4.29 /

+0.255 (+6.32%)

09:39
06/04/21
06/04
09:39
06/04/21
09:39

Taronis Fuels appoints Kevin Foti as CEO

Taronis Fuels announced several important developments, including naming Kevin Foti as CEO, the addition of Wilbur Ross to the Company's Board of Directors, and the closing of a private placement of approximately $16.5M of common stock to institutional and accredited investors to permit the Company to reduce debt obligations and pursue several important growth initiatives. The private placement was completed at a fixed price of $3.00 per share of common stock, with no warrants issued to investors. Foti has over 30 years of experience in the industrial gas business with Praxair, Inc. / Linde PLC where he most recently served for four years as President of the multi-billion US industrial gas merchant and on-site business. Foti joined the Company's Board of Directors on June 4, 2021 and will commence serving as the Company's CEO on June 14, 2021. Taronis Fuels is equally excited to welcome Wilbur Ross to the Company's Board of Directors. Mr. Ross' career has included most recently serving his country as Secretary of Commerce. As part of Kevin Foti and Wilbur Ross joining the Board, Tom Wetherald and Peter Molloy will step down at the end of 2021 enabling a smooth transition. At approximately 55 days following the replacement of the prior management team, the Company is providing an update on the new Board's 100-day plan. The new Board pledged to analyze the needs of the business and to make impactful and deliberate decisions. The Company recently completed that analysis which led to the following actions: Management has finished its initial assessment around reducing the high fixed expenses of the Company. This led to ceasing the Company's international operations, re-focusing R&D around commercial production efforts, and integrating the Company's accounting teams into corporate. This included some difficult decisions to reduce staff which is now complete. The Board thanks all of those impacted for their contributions to the Company. The next phase of cost actions will focus on operating expense reductions, including sub-leasing certain office space as well justifying all G&A spend. The Company's accounting team, led by CFO Mary Pat Thompson, has been working diligently to restate the Company's financial statements. This effort has included working openly with the SEC, engaging external forensic audit and IT consultants, and investing in the Company's internal accounting team. This process is progressing well and should be completed in Q4 2021. This effort is a critical step in restoring confidence in the Company and completing an uplisting by the end of this year. The Company completed today a private placement of approximately $16.5 million of its shares of common stock at a fixed price of $3.00 per share to institutional and accredited investors led by the Company's newest board member Wilbur Ross. This is in addition to the $4.25m bridge financing previously announced which was also priced at $3.00 per share. This capital will allow the Company to complete several growth initiatives, retire debt obligations to sellers, invest in high return capital investments and pursue several complementary acquisitions. The Company anticipates this capital will fund the business through the anticipated uplisting in Q4 2021. Notably, this capital raise included significant insider participation, with no less than 10 senior employees and Board members making new investments into this round. Kingswood Capital Markets, division of Benchmark Investments, Inc., acted as the exclusive placement agent for the transaction. The Company has completed its initial review of MagneGas which has resulted in new and expanded distribution in the US market. The characteristics of this fuel which include that is it renewable or "green", safer, and more cost effective than Acetylene in many applications remain an enormous market opportunity for the company. We anticipate sharing more news about its go-to-market strategy in Q4 2021. The Company also previously announced it will cease its international operations which were focused on selling MagneGas systems. These efforts would have required large incremental amounts of capital which offered a lower risk adjusted return than US opportunities.

TRNF Taronis Fuels
$4.29 /

+0.255 (+6.32%)

08/12/20
Fly Intel: Top five analyst initiations
08/12/20 Benchmark
Taronis Fuels initiated with a Speculative Buy at Benchmark
08/12/20 Benchmark
Taronis Fuels initiated with a Speculative Buy at Benchmark

TODAY'S FREE FLY STORIES

Technical Analysis
Financial Select Sector: Pivot points » 08:21
08/05/21
08/05
08:21
08/05/21
08:21
XLF

Financial Select Sector

$36.64 /

-0.28 (-0.76%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XLF Financial Select Sector
$36.64 /

-0.28 (-0.76%)

03/12/21
On The Fly: Weekly technical notes for S&P 500
XLF Financial Select Sector
$36.64 /

-0.28 (-0.76%)

XLF Financial Select Sector
$36.64 /

-0.28 (-0.76%)

Hot Stocks
Clene reports 'positive' results from its Phase 2 REPAIR clinical trials » 08:21
08/05/21
08/05
08:21
08/05/21
08:21
CLNN

Clene

$8.74 /

+0.49 (+5.94%)

Clene, along with its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLNN Clene
$8.74 /

+0.49 (+5.94%)

CLNN Clene
$8.74 /

+0.49 (+5.94%)

05/20/21 Maxim
Clene initiated with a Buy at Maxim
05/20/21 Maxim
Clene initiated with a Buy at Maxim
05/03/21 Cantor Fitzgerald
Clene initiated with an Overweight at Cantor Fitzgerald
03/29/21 Roth Capital
Clene to release results from four Phase 2 trials in 2H, says Roth Capital
CLNN Clene
$8.74 /

+0.49 (+5.94%)

CLNN Clene
$8.74 /

+0.49 (+5.94%)

Technical Analysis
Market Vectors Semiconductor: Pivot points » 08:21
08/05/21
08/05
08:21
08/05/21
08:21
SMH

Market Vectors Semiconductor

$270.50 /

+3.22 (+1.20%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SMH Market Vectors Semiconductor
$270.50 /

+3.22 (+1.20%)

SMH Market Vectors Semiconductor
$270.50 /

+3.22 (+1.20%)

Technical Analysis
Invesco QQQ Trust: Pivot points » 08:20
08/05/21
08/05
08:20
08/05/21
08:20
QQQ

Invesco QQQ Trust

$367.38 /

+0.58 (+0.16%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QQQ Invesco QQQ Trust
$367.38 /

+0.58 (+0.16%)

QQQ Invesco QQQ Trust
$367.38 /

+0.58 (+0.16%)

Recommendations
SiTime price target raised to $180 from $125 at Needham » 08:20
08/05/21
08/05
08:20
08/05/21
08:20
SITM

SiTime

$142.07 /

+3.47 (+2.50%)

Needham analyst Quinn…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SITM SiTime
$142.07 /

+3.47 (+2.50%)

06:58 Today Barclays
SiTime price target raised to $175 from $125 at Barclays
05/05/21 Roth Capital
SiTime price target lowered to $130 from $150 at Roth Capital
05/05/21 Barclays
SiTime price target lowered to $125 from $150 at Barclays
02/04/21 Roth Capital
SiTime price target raised to $150 from $130 at Roth Capital
SITM SiTime
$142.07 /

+3.47 (+2.50%)

  • 18
    Feb
Technical Analysis
Nasdaq Composite: Pivot points » 08:20
08/05/21
08/05
08:20
08/05/21
08:20
$COMP

Nasdaq Composite

/

+

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$COMP Nasdaq Composite
/

+

$COMP Nasdaq Composite
/

+

$COMP Nasdaq Composite
/

+

$COMP Nasdaq Composite
/

+

$COMP Nasdaq Composite
/

+

$COMP Nasdaq Composite
/

+

Earnings
Lifetime Brands sees 2021 adjusted EPS $1.28-$1.40, two est. $1.29 » 08:20
08/05/21
08/05
08:20
08/05/21
08:20
LCUT

Lifetime Brands

$15.64 /

+0.08 (+0.51%)

Sees 2021 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LCUT Lifetime Brands
$15.64 /

+0.08 (+0.51%)

06/11/21 DA Davidson
Lifetime Brands growth accelerating as investments bear fruit, says DA Davidson
12/17/20 DA Davidson
Lifetime Brands price target raised to $18 from $14 at DA Davidson
11/10/20 DA Davidson
Lifetime Brands upgraded to Buy from Neutral at DA Davidson
11/10/20 DA Davidson
Lifetime Brands upgraded to Buy from Neutral at DA Davidson
LCUT Lifetime Brands
$15.64 /

+0.08 (+0.51%)

Earnings
Bicycle Therapeutics reports Q2 EPS (74c), consensus (71c) » 08:20
08/05/21
08/05
08:20
08/05/21
08:20
BCYC

Bicycle Therapeutics

$29.45 /

-0.65 (-2.16%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BCYC Bicycle Therapeutics
$29.45 /

-0.65 (-2.16%)

BCYC Bicycle Therapeutics
$29.45 /

-0.65 (-2.16%)

07/15/21 Canaccord
Bicycle Therapeutics price target raised to $40 from $36 at Canaccord
07/14/21 Benchmark
Bicycle deal 'makes little sense' for Ionis, says Benchmark
07/13/21 William Blair
Bicycle collaboration a positive for Ionis, says William Blair
07/13/21 Piper Sandler
Bicycle Therapeutics price target raised to $46 from $39 at Piper Sandler
BCYC Bicycle Therapeutics
$29.45 /

-0.65 (-2.16%)

BCYC Bicycle Therapeutics
$29.45 /

-0.65 (-2.16%)

BCYC Bicycle Therapeutics
$29.45 /

-0.65 (-2.16%)

Technical Analysis
Nasdaq 100 Index: Pivot points » 08:20
08/05/21
08/05
08:20
08/05/21
08:20
NDX

Nasdaq 100 Index

/

+

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NDX Nasdaq 100 Index
/

+

Earnings
ViaSat reports Q1 non-GAAP EPS 46c, consensus 2c » 08:20
08/05/21
08/05
08:20
08/05/21
08:20
VSAT

ViaSat

$48.03 /

-0.39 (-0.81%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VSAT ViaSat
$48.03 /

-0.39 (-0.81%)

VSAT ViaSat
$48.03 /

-0.39 (-0.81%)

06/22/21 Needham
ViaSat initiated with a Buy at Needham
05/25/21 William Blair
ViaSat's full Delta deal worth $20 per share, says William Blair
04/28/21 William Blair
Delta's 'aggressive' rollout bodes well for ViaSat, says William Blair
04/01/21 Raymond James
ViaSat upgraded to Strong Buy from Outperform at Raymond James
VSAT ViaSat
$48.03 /

-0.39 (-0.81%)

Recommendations
Costco price target raised to $480 from $415 at Wells Fargo » 08:19
08/05/21
08/05
08:19
08/05/21
08:19
COST

Costco

$435.33 /

+0.34 (+0.08%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COST Costco
$435.33 /

+0.34 (+0.08%)

COST Costco
$435.33 /

+0.34 (+0.08%)

08:17 Today DA Davidson
Costco price target raised to $390 from $350 at DA Davidson
08:01 Today Oppenheimer
Costco price target raised to $480 from $450 at Oppenheimer
07:27 Today Raymond James
Costco price target raised to $460 from $415 at Raymond James
06:38 Today Loop Capital
Costco price target raised to $500 from $455 at Loop Capital
COST Costco
$435.33 /

+0.34 (+0.08%)

COST Costco
$435.33 /

+0.34 (+0.08%)

COST Costco
$435.33 /

+0.34 (+0.08%)

COST Costco
$435.33 /

+0.34 (+0.08%)

Earnings
Cheniere Energy Partners reports Q2 EPS 73c, consensus 59c » 08:19
08/05/21
08/05
08:19
08/05/21
08:19
CQP

Cheniere Energy Partners

$39.95 /

-0.725 (-1.78%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CQP Cheniere Energy Partners
$39.95 /

-0.725 (-1.78%)

CQP Cheniere Energy Partners
$39.95 /

-0.725 (-1.78%)

07/20/21
Fly Intel: Top five analyst downgrades
07/20/21 Barclays
Cheniere Energy Partners downgraded to Equal Weight from Overweight at Barclays
06/22/21 Citi
Cheniere Energy Partners price target raised to $45 from $42 at Citi
06/22/21 Citi
Cheniere Energy price target raised to $115 from $95 at Citi
CQP Cheniere Energy Partners
$39.95 /

-0.725 (-1.78%)

Earnings
Lifetime Brands reports Q2 adjusted EPS 28c, two est. (6c) » 08:19
08/05/21
08/05
08:19
08/05/21
08:19
LCUT

Lifetime Brands

$15.64 /

+0.08 (+0.51%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LCUT Lifetime Brands
$15.64 /

+0.08 (+0.51%)

06/11/21 DA Davidson
Lifetime Brands growth accelerating as investments bear fruit, says DA Davidson
12/17/20 DA Davidson
Lifetime Brands price target raised to $18 from $14 at DA Davidson
11/10/20 DA Davidson
Lifetime Brands upgraded to Buy from Neutral at DA Davidson
11/10/20 DA Davidson
Lifetime Brands upgraded to Buy from Neutral at DA Davidson
LCUT Lifetime Brands
$15.64 /

+0.08 (+0.51%)

Recommendations
Fastenal reports July sales up 4.7% to $491.71M » 08:19
08/05/21
08/05
08:19
08/05/21
08:19
FAST

Fastenal

$55.30 /

-0.65 (-1.16%)

The company reported Jule…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FAST Fastenal
$55.30 /

-0.65 (-1.16%)

FAST Fastenal
$55.30 /

-0.65 (-1.16%)

08/03/21 Loop Capital
Fastenal initiated with a Hold at Loop Capital
07/14/21 Baird
Fastenal price target raised to $58 from $54 at Baird
06/15/21
Fly Intel: Top five analyst downgrades
06/15/21 Morgan Stanley
Fastenal downgraded to Underweight from Equal Weight at Morgan Stanley
FAST Fastenal
$55.30 /

-0.65 (-1.16%)

FAST Fastenal
$55.30 /

-0.65 (-1.16%)

Recommendations
HubSpot price target raised to $670 from $585 at BMO Capital » 08:18
08/05/21
08/05
08:18
08/05/21
08:18
HUBS

HubSpot

$588.93 /

+4.21 (+0.72%)

BMO Capital analyst Keith…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HUBS HubSpot
$588.93 /

+4.21 (+0.72%)

HUBS HubSpot
$588.93 /

+4.21 (+0.72%)

07:57 Today Needham
HubSpot price target raised to $680 from $600 at Needham
07:29 Today Raymond James
HubSpot price target raised to $800 from $650 at Raymond James
06:53 Today Mizuho
HubSpot price target raised to $660 from $570 at Mizuho
06:40 Today Citi
HubSpot price target raised to $750 from $655 at Citi
HUBS HubSpot
$588.93 /

+4.21 (+0.72%)

HUBS HubSpot
$588.93 /

+4.21 (+0.72%)

Hot Stocks
KVH Industries receives $7.9M fiber optic gyro order from Escribano » 08:18
08/05/21
08/05
08:18
08/05/21
08:18
KVHI

KVH Industries

$10.55 /

-0.45 (-4.09%)

KVH Industries announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KVHI KVH Industries
$10.55 /

-0.45 (-4.09%)

KVHI KVH Industries
$10.55 /

-0.45 (-4.09%)

06/22/21 Needham
KVH Industries initiated with a Buy at Needham
KVHI KVH Industries
$10.55 /

-0.45 (-4.09%)

Recommendations
Charles River price target raised to $470 from $375 at Wells Fargo » 08:18
08/05/21
08/05
08:18
08/05/21
08:18
CRL

Charles River

$416.76 /

+5 (+1.21%)

Wells Fargo analyst Dan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRL Charles River
$416.76 /

+5 (+1.21%)

CRL Charles River
$416.76 /

+5 (+1.21%)

06:56 Today Baird
Charles River price target raised to $461 from $410 at Baird
08/04/21 Credit Suisse
Charles River assumed with a Neutral at Credit Suisse
07/20/21 Credit Suisse
Charles River price target raised to $385 from $352 at Credit Suisse
05/28/21 JPMorgan
Charles River price target raised to $390 from $375 at JPMorgan
CRL Charles River
$416.76 /

+5 (+1.21%)

Hot Stocks
Pardes Biosciences appoints Deborah Autor, Laura Hamill to board of directors » 08:18
08/05/21
08/05
08:18
08/05/21
08:18
FSII

FS Development Corp. II

$9.90 /

+0.025 (+0.25%)

, AZN

AstraZeneca

$57.30 /

-0.38 (-0.66%)

, GILD

Gilead

$69.23 /

-0.59 (-0.85%)

Pardes Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSII FS Development Corp. II
$9.90 /

+0.025 (+0.25%)

AZN AstraZeneca
$57.30 /

-0.38 (-0.66%)

GILD Gilead
$69.23 /

-0.59 (-0.85%)

FSII FS Development Corp. II
$9.90 /

+0.025 (+0.25%)

AZN AstraZeneca
$57.30 /

-0.38 (-0.66%)

08/04/21 SVB Leerink
AstraZeneca price target raised to $69 from $63 at SVB Leerink
07/21/21 Citi
AstraZeneca price target raised to 10,500 GBp from 10,000 GBp at Citi
07/13/21 Piper Sandler
Bicycle Therapeutics price target raised to $46 from $39 at Piper Sandler
06/17/21 UBS
AstraZeneca price target raised to 9,200 GBp from 8,000 GBp at UBS
GILD Gilead
$69.23 /

-0.59 (-0.85%)

07/30/21 BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
07/30/21 RBC Capital
Gilead price target raised to $84 from $81 at RBC Capital
06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
AZN AstraZeneca
$57.30 /

-0.38 (-0.66%)

GILD Gilead
$69.23 /

-0.59 (-0.85%)

AZN AstraZeneca
$57.30 /

-0.38 (-0.66%)

GILD Gilead
$69.23 /

-0.59 (-0.85%)

FSII FS Development Corp. II
$9.90 /

+0.025 (+0.25%)

AZN AstraZeneca
$57.30 /

-0.38 (-0.66%)

GILD Gilead
$69.23 /

-0.59 (-0.85%)

AZN AstraZeneca
$57.30 /

-0.38 (-0.66%)

GILD Gilead
$69.23 /

-0.59 (-0.85%)

Hot Stocks
U.S. Physical Therapy boosts dividend to 38c per share » 08:17
08/05/21
08/05
08:17
08/05/21
08:17
USPH

U.S. Physical Therapy

$117.99 /

-0.61 (-0.51%)

In response to the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
USPH U.S. Physical Therapy
$117.99 /

-0.61 (-0.51%)

USPH U.S. Physical Therapy
$117.99 /

-0.61 (-0.51%)

05/07/21 Barrington
U.S. Physical Therapy upgraded to Outperform from Market Perform at Barrington
05/03/21 Jefferies
U.S. Physical Therapy upgraded to Buy from Hold at Jefferies
02/26/21 Barrington
U.S. Physical Therapy downgraded to Market Perform from Outperform at Barrington
10/28/20 Barrington
Varian Medical downgraded to Underperform from Outperform at Barrington
USPH U.S. Physical Therapy
$117.99 /

-0.61 (-0.51%)

Hot Stocks
Eiger BioPharmaceuticals gets FDA Breakthrough Therapy Designation for avexitide » 08:17
08/05/21
08/05
08:17
08/05/21
08:17
EIGR

Eiger BioPharmaceuticals

$7.59 /

-0.29 (-3.68%)

Eiger BioPharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EIGR Eiger BioPharmaceuticals
$7.59 /

-0.29 (-3.68%)

EIGR Eiger BioPharmaceuticals
$7.59 /

-0.29 (-3.68%)

05/11/21 Citi
Eiger BioPharmaceuticals price target raised to $26 from $23 at Citi
12/11/20 BTIG
Gilead investment says Hepatitis Delta opportunity is 'real,' says BTIG
EIGR Eiger BioPharmaceuticals
$7.59 /

-0.29 (-3.68%)

Recommendations
Costco price target raised to $390 from $350 at DA Davidson » 08:17
08/05/21
08/05
08:17
08/05/21
08:17
COST

Costco

/

+

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COST Costco
/

+

COST Costco
/

+

08:01 Today Oppenheimer
Costco price target raised to $480 from $450 at Oppenheimer
07:27 Today Raymond James
Costco price target raised to $460 from $415 at Raymond James
06:38 Today Loop Capital
Costco price target raised to $500 from $455 at Loop Capital
08/04/21 Baird
Costco price target raised to $475 from $430 at Baird
COST Costco
/

+

COST Costco
/

+

COST Costco
/

+

COST Costco
/

+

Recommendations
Ceridian price target raised to $115 from $110 at Wells Fargo » 08:17
08/05/21
08/05
08:17
08/05/21
08:17
CDAY

Ceridian

$100.03 /

+2.54 (+2.61%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CDAY Ceridian
$100.03 /

+2.54 (+2.61%)

CDAY Ceridian
$100.03 /

+2.54 (+2.61%)

06/30/21
Fly Intel: Top five analyst downgrades
06/30/21 Barclays
Ceridian downgraded to Underweight from Equal Weight at Barclays
06/15/21
Fly Intel: Top five analyst downgrades
06/15/21 Needham
Ceridian downgraded to Hold from Buy at Needham
CDAY Ceridian
$100.03 /

+2.54 (+2.61%)

  • 19
    Nov
  • 26
    Aug
CDAY Ceridian
$100.03 /

+2.54 (+2.61%)

Earnings
U.S. Physical Therapy sees FY21 EPS $3.05- $3.15, consensus $2.74 » 08:16
08/05/21
08/05
08:16
08/05/21
08:16
USPH

U.S. Physical Therapy

$117.99 /

-0.61 (-0.51%)

Management currently…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
USPH U.S. Physical Therapy
$117.99 /

-0.61 (-0.51%)

USPH U.S. Physical Therapy
$117.99 /

-0.61 (-0.51%)

05/07/21 Barrington
U.S. Physical Therapy upgraded to Outperform from Market Perform at Barrington
05/03/21 Jefferies
U.S. Physical Therapy upgraded to Buy from Hold at Jefferies
02/26/21 Barrington
U.S. Physical Therapy downgraded to Market Perform from Outperform at Barrington
10/28/20 Barrington
Varian Medical downgraded to Underperform from Outperform at Barrington
USPH U.S. Physical Therapy
$117.99 /

-0.61 (-0.51%)

Hot Stocks
Nuwellis to make renal therapy device for children, babies under $1.7M NIH grant » 08:16
08/05/21
08/05
08:16
08/05/21
08:16
NUWE

Nuwellis

$4.22 /

-0.18 (-4.09%)

Nuwellis plans to develop…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NUWE Nuwellis
$4.22 /

-0.18 (-4.09%)

NUWE Nuwellis
$4.22 /

-0.18 (-4.09%)

Hot Stocks
Designer Brands, Hush Puppies announce exclusive wholesale partnership » 08:16
08/05/21
08/05
08:16
08/05/21
08:16
DBI

Designer Brands

$13.28 /

-1.46 (-9.91%)

, WWW

Wolverine World Wide

$34.21 /

-0.995 (-2.83%)

Designer Brands (DBI)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DBI Designer Brands
$13.28 /

-1.46 (-9.91%)

WWW Wolverine World Wide
$34.21 /

-0.995 (-2.83%)

DBI Designer Brands
$13.28 /

-1.46 (-9.91%)

03/17/21 Deutsche Bank
Designer Brands price target raised to $14 from $12 at Deutsche Bank
01/21/21 Deutsche Bank
Designer Brands price target raised to $12 from $7 at Deutsche Bank
01/08/21 CL King
Designer Brands named a top pick for 2021 at CL King
11/09/20 UBS
Designer Brands initiated with a Neutral at UBS
WWW Wolverine World Wide
$34.21 /

-0.995 (-2.83%)

08/04/21 Baird
Wolverine World Wide price target raised to $49 from $45 at Baird
08/03/21 Wells Fargo
Athleta 'highly undervalued' withing Gap, says Wells Fargo
07/30/21 Pivotal Research
Wolverine World Wide price target raised to $53 from $50 at Pivotal Research
06/10/21 Baird
Wolverine World Wide price target raised to $45 from $42 at Baird
DBI Designer Brands
$13.28 /

-1.46 (-9.91%)

WWW Wolverine World Wide
$34.21 /

-0.995 (-2.83%)

WWW Wolverine World Wide
$34.21 /

-0.995 (-2.83%)

DBI Designer Brands
$13.28 /

-1.46 (-9.91%)

WWW Wolverine World Wide
$34.21 /

-0.995 (-2.83%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.